Name: AVIDITY BIOSCIENCES INC (RNA) Stock
Brand: AVIDITY BIOSCIENCES INC
Rating: 7 (3 reviews)

RNA Latest News, Press Relases and Analysis

All

Press Releases

7 hours ago - By: The Motley Fool - Mentions: MBX MDGL CGEM TRVI ...

This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones

5 days ago - By: The Motley Fool - Mentions: MLTX MDGL CGEM TRVI ...

Biotech Fund Reveals $15 Million MoonLake Exit After Stock’s 90% Crash

8 days ago - By: Zacks Investment Research - Mentions: SRPT PEPG

Sarepta's Stock Rises on Positive Updates on DM1 Therapy

14 days ago - By: Benzinga

Here's How Much $100 Invested In Avidity Biosciences 5 Years Ago Would Be Worth Today

14 days ago - By: Benzinga

Looking Into Avidity Biosciences Inc's Recent Short Interest

8 days ago - By: Zacks Investment Research - Mentions: NVS FOLD

FDA Greenlights Novartis' Gene Replacement Treatment for SMA

12 days ago - By: Halper Sadeh LLC - Mentions: WTRG TCBX

Halper Sadeh LLC Encourages WTRG, RNA, TCBX Shareholders to Contact the Firm to Discuss Their Rights

12 days ago - By: Zacks Investment Research - Mentions: NVS FOLD

NVS Ups Sales Projections as Key Drugs and Collaborations Fuel Growth

14 days ago - By: Avidity Biosciences, Inc.

Avidity Biosciences Announces U.S. Managed Access Program (MAP) for Investigational Therapy del-zota in DMD44

23 days ago - By: Zacks Investment Research - Mentions: MXCT

Avidity Biosciences, Inc. (RNA) Reports Q3 Loss, Beats Revenue Estimates

23 days ago - By: Avidity Biosciences, Inc.

Avidity Biosciences Reports Third Quarter 2025 Financial Results and Recent Highlights

a month ago - By: Brodsky & Smith LLC - Mentions: WTRG CADE PLYM AWK ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Essential Utilities, Inc. (NYSE – WTRG), Cadence Bank (NYSE – CADE), Avidity Biosciences, Inc. (Nasdaq – RNA), Plymouth Industrial REIT, Inc. (NYSE – PLYM)

a month ago - By: Zacks Investment Research - Mentions: OVID

Ovid Therapeutics (OVID) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

a month ago - By: Zacks Investment Research - Mentions: QURE

Analysts Estimate Avidity Biosciences, Inc. (RNA) to Report a Decline in Earnings: What to Look Out for

a month ago - By: Halper Sadeh LLC

RNA Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Avidity Biosciences, Inc. is Fair to Shareholders

a month ago - By: Ademi LLP

Shareholder Alert: The Ademi Firm investigates whether Avidity Biosciences Inc. is obtaining a Fair Price for its Public Shareholders

a month ago - By: Halper Sadeh LLC

RNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Avidity Biosciences, Inc. Is Fair to Shareholders

a month ago - By: Kahn Swick & Foti, LLC

Avidity Biosciences Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avidity Biosciences, Inc. - RNA

a month ago - By: Brodsky & Smith LLC - Mentions: WTRG CADE PLYM AWK ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Essential Utilities, Inc. (NYSE – WTRG), Cadence Bank (NYSE – CADE), Avidity Biosciences, Inc. (Nasdaq – RNA), Plymouth Industrial REIT, Inc. (NYSE – PLYM)

a month ago - By: Stocktwits - Mentions: SPY QCOM TSLA NTLA ...

AVIDITY BIOSCIENCES INC (RNA) Stock News

RNA Latest News, Press Relases and Analysis

This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones

Biotech Fund Reveals $15 Million MoonLake Exit After Stock’s 90% Crash

Sarepta's Stock Rises on Positive Updates on DM1 Therapy

Here's How Much $100 Invested In Avidity Biosciences 5 Years Ago Would Be Worth Today

Looking Into Avidity Biosciences Inc's Recent Short Interest

FDA Greenlights Novartis' Gene Replacement Treatment for SMA

Halper Sadeh LLC Encourages WTRG, RNA, TCBX Shareholders to Contact the Firm to Discuss Their Rights

NVS Ups Sales Projections as Key Drugs and Collaborations Fuel Growth

Avidity Biosciences Announces U.S. Managed Access Program (MAP) for Investigational Therapy del-zota in DMD44

Avidity Biosciences, Inc. (RNA) Reports Q3 Loss, Beats Revenue Estimates

Avidity Biosciences Reports Third Quarter 2025 Financial Results and Recent Highlights

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Essential Utilities, Inc. (NYSE – WTRG), Cadence Bank (NYSE – CADE), Avidity Biosciences, Inc. (Nasdaq – RNA), Plymouth Industrial REIT, Inc. (NYSE – PLYM)

Ovid Therapeutics (OVID) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

Analysts Estimate Avidity Biosciences, Inc. (RNA) to Report a Decline in Earnings: What to Look Out for

RNA Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Avidity Biosciences, Inc. is Fair to Shareholders

Shareholder Alert: The Ademi Firm investigates whether Avidity Biosciences Inc. is obtaining a Fair Price for its Public Shareholders

RNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Avidity Biosciences, Inc. Is Fair to Shareholders

Avidity Biosciences Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avidity Biosciences, Inc. - RNA

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Essential Utilities, Inc. (NYSE – WTRG), Cadence Bank (NYSE – CADE), Avidity Biosciences, Inc. (Nasdaq – RNA), Plymouth Industrial REIT, Inc. (NYSE – PLYM)

Qualcomm, Tesla, Intellia Therapeutics, Avidity Biosciences, Dyne Therapeutics: Stocks Making The Biggest Moves Today